Summary: A case of complete atrioventricular block associated with primary cardiac lymphoma reversed without cardiac pacemaker implantation.

Summary: Odronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort in a single-arm, multicentre, phase 1 trial.

Summary: A drug profile on selinexor for the treatment of refractory diffuse large B-cell lymphoma.

Summary: Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial.

Summary: Bendamustine plus rituximab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma.

Summary: Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial.

Summary: Unusual primary central nervous system T-cell/histiocyte-rich large B-cell lymphoma: a case report.

Summary: Systemic chemotherapy combined with thrombopoietin receptor agonist for the treatment of diffuse large B-cell lymphoma complicated with aplastic anemia.

Summary: Diffuse Large B-Cell Lymphoma 18 Years After Bilateral Lacrimal Gland IgG4-Related Disease: Case Report and Literature Review.

Summary: Concurrent myasthenia gravis-related cervical thymoma in a patient with diffuse large B-cell lymphoma: a case report.

Summary: Optimization of high-dose methotrexate prophylaxis for central nervous system relapse in diffuse large B-cell lymphoma: a multicenter analysis.

Summary: Clinical benefit of R-CHOP without splenectomy in stage I primary splenic diffuse large B-cell lymphoma.